citric acid, anhydrous has been researched along with Bronze Diabetes in 3 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The nature of non-transferrin-bound iron in the plasma or serum of iron-overloaded hemochromatosis patients was studied by high performance liquid chromatography (HPLC) and high resolution nuclear magnetic resonance (NMR)." | 7.67 | Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. ( Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ, 1989) |
| "Gallium scintigraphy was performed as an aid for determining the presence or absence of malignant neoplasm in two patients with hemochromatosis treated by deferoxamine." | 7.67 | Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine. ( Hoshi, H; Jinnouchi, S; Nagamachi, S; Ono, S; Watanabe, K, 1988) |
| "The nature of non-transferrin-bound iron in the plasma or serum of iron-overloaded hemochromatosis patients was studied by high performance liquid chromatography (HPLC) and high resolution nuclear magnetic resonance (NMR)." | 3.67 | Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. ( Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ, 1989) |
| "Gallium scintigraphy was performed as an aid for determining the presence or absence of malignant neoplasm in two patients with hemochromatosis treated by deferoxamine." | 3.67 | Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine. ( Hoshi, H; Jinnouchi, S; Nagamachi, S; Ono, S; Watanabe, K, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melefors, O | 1 |
| Hentze, MW | 1 |
| Grootveld, M | 1 |
| Bell, JD | 1 |
| Halliwell, B | 1 |
| Aruoma, OI | 1 |
| Bomford, A | 1 |
| Sadler, PJ | 1 |
| Nagamachi, S | 1 |
| Hoshi, H | 1 |
| Jinnouchi, S | 1 |
| Ono, S | 1 |
| Watanabe, K | 1 |
1 review available for citric acid, anhydrous and Bronze Diabetes
| Article | Year |
|---|---|
Iron regulatory factor--the conductor of cellular iron regulation.
Topics: Aconitate Hydratase; Animals; Biological Transport; Citrates; Citric Acid; Gene Expression Regulatio | 1993 |
2 other studies available for citric acid, anhydrous and Bronze Diabetes
| Article | Year |
|---|---|
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
Topics: Acetates; Bleomycin; Chlorides; Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferox | 1989 |
Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.
Topics: Citrates; Citric Acid; Deferoxamine; Female; Gallium Radioisotopes; Hemochromatosis; Humans; Male; M | 1988 |